GJB2 AK™PCR Mutation Screen Kit

About Akcell Biotech

Founded in 2018 and headquartered in North Miami, Florida, Akcell Biotech is a private, early-revenue stage company operating in the molecular diagnostics space. Its core business involves the sale of proprietary 'AK™PCR' mutation screen kits for key genetic targets like JAK2, BRAF, BRCA1, and KRAS, used in diagnosing various cancers and genetic conditions. The company also lists genomic services, including CRISPR editing and sequencing, suggesting a broader technology services platform alongside its product portfolio.

Therapeutic Areas